Features of the AVCJ April 28 2020 issue: Australia: What does proprietary mean? COVID-19: The intricacies of MAC clauses Funds: Advantage's rapid Japan fundraise LP interview: Roc Partners' Asia...
PAG Asia Capital has acquired Australia-based Unispace with a view to expanding the office design and construction consultancy across Asia.
Suzhou Medilink Therapeutics, a Chinese biotech company specializing in antibody-drug conjugates (ADCs) commonly used as targeted therapies for treating cancer, has raised $50 million in Series A funding across two tranches.
OrbiMed has closed its latest Asia life sciences fund, which primarily invests in China and India, with $800 million in commitments.